NEW YORK (GenomeWeb) – Danaher reported on Thursday that its third quarter revenues rose 18 percent, year over year.

For the quarter ended Sept. 30, the company reported revenues of $4.13 billion, up from $3.51 billion in Q3 2015, and in line with the expectations of Wall Street analysts.

"Our team executed well despite the economic backdrop, and we were pleased with our performance in the third quarter as the strength and diversity of our portfolio continued to be a key differentiator," said President and CEO Thomas Joyce in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.